Area of research
Molecular Biology · Oncology
Research interest
Research interests include Epigenetics and DNA Methylation, Pancreatic and Hepatic Oncology Research, Histone Deacetylase Inhibitors Research, and Renal cell carcinoma treatment.
Aging-like Spontaneous Epigenetic Silencing Facilitates Wnt Activation, Stemness, and BrafV600E-Induced Tumorigenesis
DNA Methylation Patterns Separate Senescence from Transformation Potential and Indicate Cancer Risk
Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers
Epigenetic Therapeutics: A New Weapon in the War Against Cancer
Neutrophil-to-lymphocyte Ratio is a Predictive Marker for Invasive Malignancy in Intraductal Papillary Mucinous Neoplasms of the Pancreas
Epigenetic therapy in gastrointestinal cancer: the right combination
A Combination of Molecular Markers and Clinical Features Improve the Classification of Pancreatic Cysts
Survival Following Lung Metastasectomy in Soft Tissue Sarcomas
Immune regulation by low doses of the DNA methyltransferase inhibitor 5-azacitidine in common human epithelial cancers
The Impact of Postoperative Complications on the Administration of Adjuvant Therapy Following Pancreaticoduodenectomy for Adenocarcinoma
Prognostic value of CpG island methylator phenotype among colorectal cancer patients: a systematic review and meta-analysis
2564 resected periampullary adenocarcinomas at a single institution: trends over three decades
Novel Methylation Biomarker Panel for the Early Detection of Pancreatic Cancer
Incidence and prognostic impact of KRAS and BRAF mutation in patients undergoing liver surgery for colorectal metastases
The CpG Island Methylator Phenotype: What's in a Name?
Is It Necessary to Follow Patients after Resection of a Benign Pancreatic Intraductal Papillary Mucinous Neoplasm?
Is Minimally Invasive Colon Resection Better Than Traditional Approaches?
Management and Recurrence Patterns of Desmoids Tumors: A Multi-institutional Analysis of 211 Patients
Biomarkers for detection and prognosis of breast cancer identified by a functional hypermethylome screen